2m 2m 2m 2m 2m 2m 2m
Halozyme Therape (HALO)
NASDAQ
$73.99-$2.12 (-2.79%)
Price as of Jul 14, 2026 5:52 AM EDT- $9.0BMarket Cap
- 32.02%1-Year Change
- BiotechnologyIndustry
Halozyme Therape (HALO)
$73.99-$2.12 (-2.79%)
Earnings Score
Valuation | HALO | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | 0 | ||
Growth | -0 | ||
Low Earnings Volatility | 1 |
Momentum Score
Valuation | HALO | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 7.75% | ||
12-Month Momentum | 23.36% | ||
3-Month Risk Adjusted Momentum | 55.01% | ||
12-Month Risk Adjusted Momentum | 79.21% |
True Yield
Valuation | HALO | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | 0.51% | ||
Net Debt Paydown Yield | -0.03% |
Financial Health Score
Valuation | HALO | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 5 |